Theranostic Protein Targeting ErbB2 for Bioluminescence Imaging and Therapy for Cancer

A combination of molecular-targeted cancer imaging and therapy is an emerging strategy to improve cancer diagnosis and minimize the side effects of conventional treatments. Here, we generated a recombinant protein, EC1-GLuc-p53C, by fusing EC1 peptide, an artificial ligand of ErbB2, with Gaussia luc...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiao-Jian, Sun, Ling-Fei, Nishiyama, Yuki, Feng, Bin, Michiue, Hiroyuki, Seno, Masaharu, Matsui, Hideki, Tomizawa, Kazuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775930/
https://www.ncbi.nlm.nih.gov/pubmed/24069396
http://dx.doi.org/10.1371/journal.pone.0075288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775930/
https://www.ncbi.nlm.nih.gov/pubmed/24069396
http://dx.doi.org/10.1371/journal.pone.0075288

Ejemplares similares